ZyVersa Therapeutics, Inc.
ZVSA
$0.6794
-$0.0306-4.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.61M | 1.53M | 122.90K | 119.50K | 2.03M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 498.80K | 184.90K | 267.50K | 521.90K | 866.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 2.11M | 1.72M | 390.40K | 641.40K | 2.90M |
|
|
|||||
| Total Current Assets | 2.11M | 1.72M | 390.40K | 641.40K | 2.90M |
| Net Property, Plant & Equipment | -- | 0.00 | -- | 1.70K | 4.30K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 18.65M | 18.65M | 18.65M | 18.65M | 18.65M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 227.30K | 235.70K | 385.60K | 178.50K | 98.50K |
| Total Assets | 20.99M | 20.60M | 19.42M | 19.47M | 21.65M |
|
|
|||||
| Total Accounts Payable | 9.60M | 9.34M | 9.28M | 8.32M | 8.13M |
| Total Accrued Expenses | 2.39M | 1.89M | 2.25M | 1.67M | 1.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 7.30K | 7.30K | 7.30K | 7.30K | 7.30K |
| Total Other Current Liabilities | 7.30K | 7.30K | 7.30K | 7.30K | 7.30K |
| Total Current Liabilities | 12.00M | 11.23M | 11.54M | 9.99M | 9.58M |
|
|
|||||
| Total Current Liabilities | 12.00M | 11.23M | 11.54M | 9.99M | 9.58M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 851.70K | 851.70K | 854.60K | 854.60K | 844.90K |
| Total Liabilities | 12.86M | 12.08M | 12.40M | 10.85M | 10.43M |
|
|
|||||
| Common Stock & APIC | 123.03M | 121.16M | 118.25M | 117.44M | 117.28M |
| Retained Earnings | -114.89M | -112.63M | -111.21M | -108.81M | -106.05M |
| Treasury Stock & Other | -7.20K | -7.20K | -7.20K | -7.20K | -7.20K |
| Total Common Equity | 8.13M | 8.52M | 7.03M | 8.62M | 11.22M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
|
|
|||||
| Total Common Equity | 8.13M | 8.52M | 7.03M | 8.62M | 11.22M |
| Total Preferred Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 8.13M | 8.52M | 7.03M | 8.62M | 11.22M |
|
|
|||||